Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>MCL R
>
Treatment
>
Co: USA. C. Brand Lenalidomide Cap>
>
Patent>USA Expiration: 2019. 12.31.
Patent>USA Expiration: 2019. 12.31.'s products
This section has no products